Cover image of the article: Comparison of HCV Prevalence in Pakistan and Iran; An Insight into Future

Image Credit:Hepat Mon

Comparison of HCV Prevalence in Pakistan and Iran; An Insight into Future

Authors

Muhammad Sohail Afzal1,*, Tahir Ahmed1, Najam us Sahar Sadaf Zaidi1
1Atta ur Rahman School of Applied Biosciences, National University of Science and Technology, Islamabad, Pakistan
*Corresponding Author: Muhammad Sohail Afzal, Atta ur Rahman School of Applied Biosciences, National University of Science and Technology, Islamabad, Pakistan. Tel: +92-3215244808, Fax: +92-5190856102, E-mail: Email: sohail.ncvi@gmail.com

Hepatitis Monthly:Vol. 14, issue 1; e11466
Published online:Jan 12, 2014
Article type:Letter
Received:Apr 09, 2013
Accepted:Apr 28, 2013
How to Cite:Afzal MS, Ahmed T, Zaidi NUSS. Comparison of HCV Prevalence in Pakistan and Iran; An Insight into Future. Hepat Mon. 2014;14(1):e11466. doi: https://doi.org/10.5812/hepatmon.11466

Dear Editor,
A recent report by Shakeri et al. (March, 2013) published in Hepatitis Monthly showed that HCV prevalence is 0.2% in Mashad, Iran (1). Moreover, Previous report from Iran showed the similar prevalence of HCV in voluntaries blood donors (2). Pakistan, a neighboring country of Iran, is a low socioeconomic country having more than 10 million HCV infected people (3). Recently we have published the prevalence of HCV among 62,251 healthy blood donors from North West Province of Pakistan. The study showed that 2.6 % of healthy individuals were HCV antibody positive (4). We also concluded that the HCV prevalence is increasing with time when the results were compared with other previous reports.
HCV with more than 180 million infections worldwide (5), can lead to chronic infection and hepatocellular carcinoma (HCC) in 60% to 80% of infected individuals (6). Genetic differences among different ethnic groups results in differential susceptibility of infection and 20 % of infected individuals can clear the virus naturally due to their genetic makeup (7, 8). Better understanding of genetic factors, which are differentially distributed among different ethnic groups and have effect on hepatitis C susceptibility, progression, pathogeneses, would provide a scientific basis for HCV differential prevalence. Complete understanding the underlying molecular mechanisms involved in immune regulation in HCV infected patients will help in the development of new immunomodulatory treatments.
Currently there is no vaccine available to control HCV largely due to its unpredictable genomic variations. As Pakistani population is more affected with this deadly virus, a large proportion of infected individuals are in danger of developing cirrhosis and hepatocellular carcinoma. In Iran, the situation in not alarming currently but there is a need to conduct the continuous and regular prevalence studies on larger scale. As the incidence of HCV infection in Pakistan is increasing with time, the HCV prevalence studies are recommended in Iran on regular intervals to estimate the actual infection rate of HCV. Massive awareness campaigns are also needed to educate the general population about the roots of HCV spread and prevention methods to contain the deadly virus spread. It is observed that barbers and dentists are the major cause of viral spread in healthy population. Therefore, it is necessary to educate the barbers and dentists in Iran and their practices should be supervised more efficiently according to HCV safety protocols.

Acknowledgments

Footnotes

  • Implication for health policy/practice/research/medical education:Currently the prevalence of HCV is low in Iran. Viral spread is going to increase with the passage of time. Barbers and dentists practice procedures should also be standarized with HCV safety guidelines. It is highly needed to start massive awareness campaign in Iran against HCV to educate general population to contain the viral spread over time.

  • Authors’ Contribution:Study concept, design and manuscript drafting: Muhammad Sohail Afzal, Tahir Ahmed, Najam us Sahar Sadaf Zaidi.

  • Financial Disclosure:There is no financial interest related to the material in the manuscript.

  • Funding/Support:This study was supported by Higher Education Commission Pakistan and National University of Sciences and Technology, Islamabad, Pakistan.

References

  • 1.
    Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, et al. The prevalence of hepatitis C virusin mashhad, iran: a population-based study. Hepat Mon. 2013;13(3). ee7723. [PubMed ID: 23745128]. https://doi.org/10.5812/hepatmon.7723.
  • 2.
    Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol. 2002;17(10):1092-7. [PubMed ID: 12201870].
  • 3.
    Anjum S, Ali S, Ahmad T, Afzal MS, Waheed Y, Shafi T, et al. Sequence and structural analysis of 3' untranslated region of hepatitis C virus, genotype 3a, from pakistani isolates. Hepat Mon. 2013;13(5). ee8390. [PubMed ID: 23922562]. https://doi.org/10.5812/hepatmon.8390.
  • 4.
    Safi SZ, Afzal MS, Waheed Y, Butt UJ, Fatima K, Pervez Y, et al. Seroprevalence of hepatitis C and human immunodeficiency viruses in blood donors of northwestern Pakistan. Asian Biomed. 2011;5(3):389.
  • 5.
    Waheed Y, Saeed U, Anjum S, Afzal MS, Ashraf M. Development of Global Consensus Sequence and Analysis of Highly Conserved Domains of the HCV NS5B Prote in. Hepat Mon. 2012;12(9). ee6142. [PubMed ID: 23087757]. https://doi.org/10.5812/hepatmon.6142.
  • 6.
    Alavian SM. Triangular clinics: The way of the future. Hepat Mon. 2005;5(3):51-2.
  • 7.
    Afzal MS, Tahir S, Salman A, Baig TA, Shafi T, Zaidi NU, et al. Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan. J Infect Dev Ctries. 2011;5(6):473-9. [PubMed ID: 21727647].
  • 8.
    Afzal MS, Anjum S, Zaidi NU. Effect of Functional Interleukin-10 Polymorphism on Pegylated Interferon-alpha Plus Ribavirin Therapy Response in Chronic Hepatitis C Virus Patients Infected With 3a Genotype in Pakistani Population. Hepat Mon. 2013;13(6). ee10274. [PubMed ID: 24032042]. https://doi.org/10.5812/hepatmon.10274.

Copyright

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Similar Articles

30
Sep
2010
Hepatitis C in Pakistan: A Review of Available Data

Hepatitis C in Pakistan: A Review of Available Data

Hamama Bushra,
Masood Ahmad,
Muhammad Khurram,
Saima Usman,
Mohammad Arif,
Tashfeen Adam
,et al.

Bushra H, Ahmad M, Khurram M, Usman S, Arif M, et al. Hepatitis C in Pakistan: A Review of Available Data. Hepat Mon. 2010;10(3):. doi:

31
Dec
2007
Comparison of Seroepidemiology and Transmission Modes of Viral Hepatitis B in Iran and Pakistan

Comparison of Seroepidemiology and Transmission Modes of Viral Hepatitis B in Iran and Pakistan

Seyed Moayed Alavian,
Farahnaz Fallahian,
Kamran Bagheri Lankarani

Alavian S, Fallahian F, Lankarani K. Comparison of Seroepidemiology and Transmission Modes of Viral Hepatitis B in Iran and Pakistan. Hepat Mon. 2007;7(4):. doi:

1
Oct
2009
Epidemiology of Hepatitis C in Iran and the World.

Epidemiology of Hepatitis C in Iran and the World.

SM Alavian,
F Fallahian

Alavian S, Fallahian F. Epidemiology of Hepatitis C in Iran and the World.. Shiraz E-Med J. 2009;10(4):. doi:

15
Oct
2016
Healthcare and the Preventable Silent Killer: The Growing Epidemic of Hepatitis C in Pakistan

Healthcare and the Preventable Silent Killer: The Growing Epidemic of Hepatitis C in Pakistan

Kamiar Alaei,
Mohammad Sarwar,
Shao Chiu Juan,
Arash Alaei

Alaei K, Sarwar M, Juan SC, Alaei A. Healthcare and the Preventable Silent Killer: The Growing Epidemic of Hepatitis C in Pakistan. Hepat Mon. 2016;16(11):e41262. doi: https://doi.org/10.5812/hepatmon.41262

31
Jul
2012
Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, november 2011, Tehran, Iran

Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, november 2011, Tehran, Iran

Seyed Moayed Alavian,
Hossain Jabbari,
Nasser Ebrahimi Daryani,
Mohammad Torabi Nami

Alavian SM, Jabbari H, Ebrahimi Daryani N, Torabi Nami M. Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, november 2011, Tehran, Iran. Hepat Mon. 2012;12(7):. doi: https://doi.org/10.5812/hepatmon.6679

More by these authors

Muhammad Sohail AfzalPubMedScholar
Tahir AhmedPubMedScholar
Najam us Sahar Sadaf ZaidiPubMedScholar
Share
Cited by
Metrics